Results 121 to 130 of about 4,141 (163)

Pharmacology of Auranofin: Overview and Update

Scandinavian Journal of Rheumatology, 1986
Auranofin, the only approved oral gold complex of value in suppressing rheumatoid arthritis, differs from injectable gold compounds molecularly and pharmacologically. Although comparably efficacious, the side-effect profiles of oral and intramuscular gold differ, and the withdrawal rate for adverse reactions is several-fold lower with auranofin ...
openaire   +2 more sources

Auranofin⋆

Reactions, 1986
  +4 more sources

The rheumatoid arthritis drug auranofin lowers leptin levels and exerts antidiabetic effects in obese mice

Cell Metabolism, 2022
Natasha Chernis, Huaizhu Wu, Sean Hartig   +2 more
exaly  

Auranofin

Reactions Weekly, 1992
openaire   +2 more sources

Upgrade of an old drug: Auranofin in innovative cancer therapies to overcome drug resistance and to increase drug effectiveness

Medicinal Research Reviews, 2022
Flavia Sorbi, Francesca Magherini, Giovanni Chiappetta   +2 more
exaly  

Repurposing of the gold drug auranofin and a review of its derivatives as antibacterial therapeutics

Drug Discovery Today, 2022
Wukun Liu, Zhongren Xu, Yunlong Lu
exaly  

Gold Nanoclusters as Nanoantibiotic Auranofin Analogues

Advanced Healthcare Materials, 2022
N G Hasitha Raviranga, Olof Ramstrom, Mingdi Yan   +2 more
exaly  

Auranofin

Reactions Weekly, 1993
openaire   +1 more source

Auranofin

Reactions, 1988
openaire   +2 more sources

Antivirulence activity of auranofin against vancomycin-resistant enterococci: in vitro and in vivo studies

International Journal of Antimicrobial Agents, 2020
Mohamed N Seleem, Nader S Abutaleb
exaly